{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-060813","form_type":"8-K","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.520832+00:00","generated_at":"2026-06-15T00:48:33.404881+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cara Therapeutics updates pipeline timelines; cash $123M, runway into 2H2024","bullets":["KORSUVA injection US launch ongoing; Japan approval expected 2H2023; EU launch 2H2022.","Oral difelikefalin Phase 3 for non-dialysis CKD-aP (KICK1/2) topline data 2H2024.","Phase 3 for atopic dermatitis (KIND1/2) internal readout 4Q2023, topline 1H2025.","Phase 2/3 for notalgia paresthetica (KOURAGE1) internal readout 2H2024.","Cash $123M as of Mar 31, 2023; no debt; cash runway into 2H2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-060813","json":"https://secwatch.observer/filing/0001104659-23-060813.json","markdown":"https://secwatch.observer/filing/0001104659-23-060813.md","text":"https://secwatch.observer/filing/0001104659-23-060813.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465923060813/0001104659-23-060813-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465923060813/tm2315680d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:48:33.404881+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}